107 related articles for article (PubMed ID: 30440488)
1. Analysis of DCE-MRI for Early Prediction of Breast Cancer Therapy Response.
Machireddy A; Thibault G; Huang W; Song X
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():682-685. PubMed ID: 30440488
[TBL] [Abstract][Full Text] [Related]
2. Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps.
Machireddy A; Thibault G; Tudorica A; Afzal A; Mishal M; Kemmer K; Naik A; Troxell M; Goranson E; Oh K; Roy N; Jafarian N; Holtorf M; Huang W; Song X
Tomography; 2019 Mar; 5(1):90-98. PubMed ID: 30854446
[TBL] [Abstract][Full Text] [Related]
3. Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study.
Thawani R; Gao L; Mohinani A; Tudorica A; Li X; Mitri Z; Huang W
BMC Med Imaging; 2022 Oct; 22(1):182. PubMed ID: 36266631
[TBL] [Abstract][Full Text] [Related]
4. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MRI texture analysis for pretreatment prediction of clinical and pathological response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Teruel JR; Heldahl MG; Goa PE; Pickles M; Lundgren S; Bathen TF; Gibbs P
NMR Biomed; 2014 Aug; 27(8):887-96. PubMed ID: 24840393
[TBL] [Abstract][Full Text] [Related]
6. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
Wu J; Gong G; Cui Y; Li R
J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
[TBL] [Abstract][Full Text] [Related]
7. Response to neoadjuvant treatment of invasive ductal breast carcinomas including outcome evaluation: MRI analysis by an automatic CAD system in comparison to visual evaluation.
Böttcher J; Renz DM; Zahm DM; Pfeil A; Fallenberg EM; Streitparth F; Maurer MH; Hamm B; Engelken FJ
Acta Oncol; 2014 Jun; 53(6):759-68. PubMed ID: 24299492
[TBL] [Abstract][Full Text] [Related]
8. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
[TBL] [Abstract][Full Text] [Related]
9. Quantitative evaluation of breast cancer response to neoadjuvant chemotherapy by diffusion tensor imaging: Initial results.
Furman-Haran E; Nissan N; Ricart-Selma V; Martinez-Rubio C; Degani H; Camps-Herrero J
J Magn Reson Imaging; 2018 Apr; 47(4):1080-1090. PubMed ID: 28901594
[TBL] [Abstract][Full Text] [Related]
10. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
[TBL] [Abstract][Full Text] [Related]
11. Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer.
Fan M; Chen H; You C; Liu L; Gu Y; Peng W; Gao X; Li L
Front Mol Biosci; 2021; 8():622219. PubMed ID: 33869279
[TBL] [Abstract][Full Text] [Related]
12. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography.
Iwasa H; Kubota K; Hamada N; Nogami M; Nishioka A
Oncol Rep; 2014 Apr; 31(4):1555-60. PubMed ID: 24535214
[TBL] [Abstract][Full Text] [Related]
14. Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer.
Minarikova L; Bogner W; Pinker K; Valkovič L; Zaric O; Bago-Horvath Z; Bartsch R; Helbich TH; Trattnig S; Gruber S
Eur Radiol; 2017 May; 27(5):1901-1911. PubMed ID: 27651141
[TBL] [Abstract][Full Text] [Related]
15. Estimating breast tumor blood flow during neoadjuvant chemotherapy using interleaved high temporal and high spatial resolution MRI.
Georgiou L; Sharma N; Broadbent DA; Wilson DJ; Dall BJ; Gangi A; Buckley DL
Magn Reson Med; 2018 Jan; 79(1):317-326. PubMed ID: 28370289
[TBL] [Abstract][Full Text] [Related]
16. Ultrafast DCE-MRI as a new tool for treatment response prediction in neoadjuvant chemotherapy of breast cancer.
Kataoka M
Diagn Interv Imaging; 2023 Dec; 104(12):565-566. PubMed ID: 37741704
[No Abstract] [Full Text] [Related]
17. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
Jun W; Cong W; Xianxin X; Daqing J
Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
[TBL] [Abstract][Full Text] [Related]
18. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
[TBL] [Abstract][Full Text] [Related]
19. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging.
Cho N; Im SA; Park IA; Lee KH; Li M; Han W; Noh DY; Moon WK
Radiology; 2014 Aug; 272(2):385-96. PubMed ID: 24738612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]